[Comment] Catheter-based renal denervation for treatment of hypertension

After the initial unprecedented enthusiasm for catheter-based renal denervation for the treatment of resistant hypertension, the negative results of the sham-controlled SYMPLICITY HTN-3 trial1 with the single-electrode radiofrequency Symplicity catheter have cast major doubts on the efficacy of this technique to treat these patients. Various factors might have contributed to these negative results.2 By contrast, the DENERHTN trial,3 which compared renal denervation plus stepped care standardised antihypertensive treatment with stepped care standardised antihypertensive treatment alone in patients with resistant hypertension, although not sham-controlled, reported a 5 –6 mm Hg difference in daytime ambulatory systolic blood pressure (SBP) in favour of renal denervation at 6 months.
Source: LANCET - Category: General Medicine Authors: Tags: Comment Source Type: research